Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Ricolinostat by Regenacy Pharmaceuticals for Diabetic Neuropathic Pain: Likelihood of Approval
Ricolinostat is under clinical development by Regenacy Pharmaceuticals and currently in Phase II for Diabetic Neuropathic Pain. According to GlobalData,...